[(2,3-dimethylimidazo[2,1-b][1,3]thiazol-6-yl)methyl]amine dihydrochloride, 95.0%, 5g

2-Aminoquinazoline, 97.0%, 1g

4-amino-3-(3-chlorophenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 250mg

tert-Butyl 4-hydroxy-4-(1H-imidazol-2-yl)piperidine-1-carboxylate, 97%, 5g

Pyrazolo[1,5-a]quinoxalin-4(5H)-one, 97.0%, 1g

Methylhydroxyethylcellulose , 3800-5300 mPas, pulv., 250 g, kunststoffverpackung.

4-Fluoro-alpha-methylbenzyl Alcohol>97.0%(GC)5g

2-Amino-4-(trifluoromethyl)phenol, 97.0%, 10g

6-hydroxy-2-(4-nitrophenyl)-1,4-dihydropyrimidin-4-one, 100mg

2-(Cyclobutylamino)isonicotinic acid, 97%, 250mg

5-(2-Bromo-4-methylphenyl)-2-furaldehyde, 95.0%, 5g

1-(diazyn-1-ium-1-yl)-16-oxo-16-(2,3,4,5,6-pentafluorophenoxy)-4,7,10,13-tetraoxa-1-azahexadecan-1-ide, 95%, 1g

2-Methylthiazol-4-amine;hydrochloride, 97%, 250mg